Hypoglycemia from a cardiologist's perspective

Clinical Cardiology

Volumn 37, Issue 8, 2014, Pages 499-504

  Sanon, Vani P ^a   Sanon, Saurabh ^b   Kanakia, Rushit ^a   Yu, Hu ^c   Araj, Faris ^a   Oliveros, Rene ^d   Chilton, Robert ^d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MAYO CLINIC   (United States)

^c FUDAN UNIVERSITY   (China)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

CARDIOLOGIST; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; HYPOGLYCEMIA; PATHOPHYSIOLOGY; QT PROLONGATION; REVIEW; ARRHYTHMIAS, CARDIAC; BLOOD; CARDIOVASCULAR DISEASES; GLUCOSE BLOOD LEVEL; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; METABOLISM; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ARRHYTHMIAS, CARDIAC; BIOMARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84906333173     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22288     Document Type: Review

References (38)

1. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the american diabetes association and the endocrine society. Diabetes Care. 2013; 36: 1384-1395.
2. Yakubovich N, Gerstein HC,. Serious cardiovascular outcomes in diabetes: the role of hypoglycemia. Circulation. 2011; 123: 342-348.
3. Duckworth W, Abraira C, Moritz T, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes [published corrections appear in N Engl J Med. 2009;361:1024-1025 and N Engl J Med. 2009;361:1028]. N Engl J Med. 2009; 360: 129-139.
4. Gerstein HC, Miller ME, Byington RP, et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358: 2545-2559.
5. Patel A, MacMahon S, Chalmers J, et al. ADVANCE Collbaorative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358: 2560-2572.
6. Riddle MC, Ambrosius WT, Brillon DJ, et al. Action to Control Cardiovascular Risk in Diabetes Investigators. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care. 2010; 33: 983-990.
7. Burge MR, Sobhy TA, Qualls CR, et al. Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms J Clin Endocrinol Metab. 2001; 86: 5471-5478.
8. Segel SA, Paramore DS, Cryer PE,. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes. 2002; 51: 724-733.
9. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012; 60: 616-631.
10. Fisher BM, Gillen G, Hepburn DA, et al. Cardiac responses to acute insulin-induced hypoglycemia in humans. Am J Physiol. 1990;258(6 part 2): H1775-H1779.
11. Frier BM, Schernthaner G, Heller SR,. Hypoglycemia and cardiovascular risks. Diabetes Care 2011; 34 (suppl 2): S132-S137.
12. Sommerfield AJ, Wilkinson IB, Webb DJ, et al. Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia. Am J Physiol Endocrinol Metab. 2007; 293: E1274-E1279.
13. Wright RJ, Frier BM,. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev. 2008; 24: 353-363.
14. Galloway PJ, Thomson GA, Fisher BM, et al. Insulin-induced hypoglycemia induces a rise in C-reactive protein. Diabetes Care. 2000; 23: 861-862.
15. Himwich H., A review of hypoglycemia, its physiology and pathology, symptomatology and treatment. Am J Digest Dis. 1944; 11: 1-8.
16. Robinson RT, Harris ND, Ireland RH, et al. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes. 2003; 52: 1469-1474.
17. Meinhold J, Heise T, Rave K, et al. Electrocardiographic changes during insulin-induced hypoglycemia in healthy subjects. Horm Metab Res. 1998; 30: 694-697.
18. Ireland RH, Robinson RT, Heller SR, et al. Measurement of high resolution ECG QT interval during controlled euglycaemia and hypoglycaemia. Physiol Meas. 2000; 21: 295-303.
19. Laitinen T, Lyyra-Laitinen T, Huopio H, et al. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Ann Noninvasive Electrocardiol. 2008; 13: 97-105.
20. Duh E, Feinglos M,. Hypoglycemia-induced angina pectoris in a patient with diabetes mellitus. Ann Intern Med. 1994; 121: 945-946.
21. Pladziewicz DS, Nesto RW,. Hypoglycemia-induced silent myocardial ischemia. Am J Cardiol. 1989; 63: 1531-1532.
22. Desouza C, Salazar H, Cheong B, et al. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care. 2003; 26: 1485-1489.
23. Marques JL, George E, Peacey SR, et al. Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabet Med. 1997; 14: 648-654.
24. Pappachan JM, Sebastian J, Bino BC, et al. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Postgrad Med J. 2008; 84: 205-210.
25. Whitsel EA, Boyko EJ, Rautaharju PM, et al. Electrocardiographic QT interval prolongation and risk of primary cardiac arrest in diabetic patients. Diabetes Care. 2005; 28: 2045-2047.
26. Ziegler D, Zentai CP, Perz S, et al. KORA Study Group. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care. 2008; 31: 556-561.
27. Gruden G, Giunti S, Barutta F, et al. QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. Diabetes Care. 2012; 35: 125-127.
28. Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010; 363: 1410-1418.
29. Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010; 340: b4909.
30. Hsu PF, Sung SH, Cheng HM, et al. Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study. Diabetes Care. 2013; 36: 894-900.
31. Malmberg K, Rydén L, Wedel H, et al. DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005; 26: 650-661.
32. Goyal A, Mehta SR, Díaz R, et al. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation. 2009; 120: 2429-2437.
33. Cox DJ, Singh H, Lorber D,. Diabetes and driving safety: science, ethics, legality and practice. Am J Med Sci. 2013; 345: 263-265.
34. ECRI. Diabetes and Commercial Motor Vehicle Driver Safety, June 2011 Update. Plymouth Meeting, PA: ECRI; June 2011.
35. Cox DJ, Penberthy JK, Zrebiec J, et al. Diabetes and driving mishaps: frequency and correlations from a multinational survey. Diabetes Care. 2003; 26: 2329-2334.
36. Cox DJ, Ford D, Gonder-Frederick L, et al. Driving mishaps among individuals with type 1 diabetes: a prospective study. Diabetes Care. 2009; 32: 2177-2180.
37. Cox DJ, Kovatchev BP, Gonder-Frederick LA, et al. Physiological and performance differences between drivers with type 1 diabetes mellitus (T1DM) with and without a recent history of driving mishaps: an exploratory study. Can J Diabetes. 2003; 27: 23-29.
38. Yancy CW, Jessup M, Bozkurt B, et al. Writing Committee Members. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128: e240-e327.